Skip to contentV
Vaxart, Inc.
V
VXRTVaxart, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$104.24M$104.24Mderived+586.5% vs Q4 2024 Net Income$55.05M$55.05MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$55,423,000N/M Operating Cash Flowderived$30,663,000N/M Free Cash Flowderived$30,662,000N/M Margins · derivedOperating margin53.2%+128.8 pt vs Q4 2024
Net margin52.8%+131.7 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 13, 2026 · 72 d after period end